Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs VNET Group Inc (VNET) Price & Performance

Adaptive Biotechnologies CorpTrade
VNET Group IncTrade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs VNET Group Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while VNET Group Inc trades at $7.54 (market cap $2.14B). The key difference: Adaptive Biotechnologies Corp is the larger of the two by market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, VNET Group Inc nearer its low. Which is the better fit depends on your goals.

ADPTVNET
Market Cap
$4.04B$2.14B
Sector
HealthTechnology
52-Week High
$25.45$14.03
52-Week Low
$12.30$6.29
Enterprise Value
$4.10B$5.29B

Returns comparison

Trailing returns across standard periods

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About VNET Group Inc

VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.

Read more on VNET